Ma Zhiwei, Huang Sheng-You, Cheng Fei, Zou Xiaoqin
Dalton Cardiovascular Research Center, Department of Physics and Astronomy, Department of Biochemistry, Institute for Data Science and Informatics, University of Missouri, Columbia, Missouri 65211, United States.
McCombs School of Business, University of Texas, Austin, Texas 78712, United States.
J Phys Chem B. 2021 Mar 11;125(9):2288-2298. doi: 10.1021/acs.jpcb.1c00016. Epub 2021 Mar 2.
Rapid identification of inhibitors for a family of proteins and prediction of ligand specificity are highly desirable for structure-based drug design. However, sequentially docking ligands into each protein target with conventional single-target docking methods is too computationally expensive to achieve these two goals, especially when the number of the targets is large. In this work, we use an efficient ensemble docking algorithm for simultaneous docking of ligands against multiple protein targets. We use protein kinases, a family of proteins that are highly important for many cellular processes and for rational drug design, as an example to demonstrate the feasibility of investigating ligand selectivity with this algorithm. Specifically, 14 human protein kinases were selected. First, native docking calculations were performed to test the ability of our energy scoring function to reproduce the experimentally determined structures of the ligand-protein kinase complexes. Next, cross-docking calculations were conducted using our ensemble docking algorithm to study ligand selectivity, based on the assumption that the native target of an inhibitor should have a more negative (i.e., favorable) energy score than the non-native targets. Staurosporine and Gleevec were studied as examples of nonselective and selective binding, respectively. Virtual ligand screening was also performed against five protein kinases that have at least seven known inhibitors. Our quantitative analysis of the results showed that the ensemble algorithm can be effective on screening for inhibitors and investigating their selectivities for multiple target proteins.
对于基于结构的药物设计而言,快速鉴定一类蛋白质的抑制剂并预测配体特异性是非常必要的。然而,使用传统的单靶点对接方法将配体依次对接至每个蛋白质靶点,在计算上过于昂贵,难以实现这两个目标,尤其是当靶点数量众多时。在这项工作中,我们使用一种高效的整体对接算法,用于将配体同时对接至多个蛋白质靶点。我们以蛋白激酶为例,蛋白激酶是一类对许多细胞过程和合理药物设计都非常重要的蛋白质,以此来证明使用该算法研究配体选择性的可行性。具体而言,选择了14种人类蛋白激酶。首先,进行天然对接计算,以测试我们的能量评分函数重现配体 - 蛋白激酶复合物实验测定结构的能力。接下来,基于抑制剂的天然靶点应比非天然靶点具有更负(即更有利)的能量评分这一假设,使用我们的整体对接算法进行交叉对接计算,以研究配体选择性。分别以星形孢菌素和格列卫作为非选择性和选择性结合的例子进行研究。还针对五种至少有七种已知抑制剂的蛋白激酶进行了虚拟配体筛选。我们对结果的定量分析表明,整体算法在筛选抑制剂以及研究它们对多个靶蛋白的选择性方面可能是有效的。